Arca
Skip to content
Tools
Tools

Tobacco use disorder

Drug research and approvals for tobacco use disorder: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 126 studies of tobacco use disorder are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 126
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 126 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 2

  • NicotineNeuronal acetylcholine receptor; alpha4/beta2 agonist
  • VareniclineNeuronal acetylcholine receptor; alpha4/beta2 agonist

Phase 3 12 of 14

Phase 2 12 of 42

Phase 1 or earlier 12 of 23

  • MidazolamGABA-A receptor; anion channel positive allosteric modulator
  • MentholTransient receptor potential cation channel subfamily M member 8 opener
  • MemantineGlutamate [NMDA] receptor negative allosteric modulator
  • KetamineGlutamate [NMDA] receptor negative allosteric modulator
  • Phenanthrene
  • HaloperidolSerotonin 2a (5-HT2a) receptor antagonist
  • LoxapineSerotonin 2a (5-HT2a) receptor antagonist
  • AtomoxetineNorepinephrine transporter inhibitor
  • OxazepamGABA-A receptor; anion channel positive allosteric modulator
  • CarbidopaDOPA decarboxylase inhibitor
  • LevodopaDopamine D3 receptor agonist
  • ModafinilDopamine transporter inhibitor

How its trials ended

907 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 222 whose ending is known, 55% met their primary endpoint, 10% missed it and 35% stopped early.

  • Completed, result not reported51156%
  • Met its primary endpoint12314%
  • Ongoing11713%
  • Status unknown576%
  • Stopped: other or unclear485%
  • Missed its primary endpoint222%
  • Stopped: enrollment or feasibility152%
  • Stopped: lack of efficacy51%
  • Stopped: sponsor or business decision51%
  • Stopped: funding4<1%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.